The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Loss on change in fair value of derivative liability | - | 0 | 0 | 0 |
| Gain on change in fair value of convertible notes | - | 281,932 | - | - |
| Amortization of debt discounts | - | 0 | 0 | 0 |
| Net loss | -2,061,958 | -2,575,031 | -2,288,034 | -3,781,832 |
| Shares issued for services | - | - | - | 66,000 |
| Prepaid and other current assets | - | - | -32,324 | 60,132 |
| Decrease in operating lease right of use asset | - | 1,107 | 639 | 1,908 |
| Loss (gain) on extinguishment of debt | - | 0 | 0 | 0 |
| Gain on forgiveness of accrued compensation | - | 0 | 0 | 0 |
| Decrease (increase) in prepaid contracts | - | 0 | - | - |
| Gain on change in fair value of convertible notes | 1,282 | - | - | - |
| Increase in prepaid and other current assets | - | 0 | - | - |
| Interest expense paid through sale of common stock | 131,479 | - | - | - |
| Amortization of prepaid contracts | 189,041 | 193,242 | 193,242 | 380,182 |
| Non-cash financing cost | - | 200,000 | - | - |
| Interest expense paid through sale of common stock | - | 22,521 | - | - |
| Stock-based compensation | 500,992 | 463,241 | 1,071,333 | 883,942 |
| Change in operating lease right of use asset and lease liabilities | -1,132 | - | - | - |
| Accounts receivable | -2,637 | 2,637 | - | - |
| Decrease in inventory | -11,722 | 159,790 | - | - |
| Increase in other liabilities | - | - | 6,695 | - |
| Other current assets | 26,154 | -7,544 | - | - |
| Accounts payable and accrued expenses | -164,010 | 160,294 | -95,612 | 177,481 |
| Accrued compensation | 25,255 | -451,695 | -8,867 | 442,826 |
| Deferred revenue | -735 | 735 | - | - |
| Refund liability | 1,874 | - | - | - |
| Accrued interest | -39,829 | 35,479 | 1,108 | 2,178 |
| Net cash used in operating activities | -1,432,100 | -2,368,023 | -1,154,450 | -1,891,263 |
| Proceeds from note payable, related parties | - | 0 | 0 | 0 |
| Payment on notes payable-Nonrelated Party | - | 0 | - | - |
| Payment on convertible note payable | - | 0 | - | - |
| Proceeds from offering, net of offering costs | - | 0 | - | - |
| Proceeds from sale of common stock | - | 0 | 0 | 0 |
| Payment on notes payable-Related Party | - | 146,432 | - | - |
| Proceeds from issuance convertible note payable, net | - | 5,580,000 | - | - |
| Proceeds from exercise of stock options | 5,507 | - | - | - |
| Net change in cash | - | 3,065,545 | - | - |
| Net cash provided by financing activities | 5,507 | 5,433,568 | 0 | 0 |
| Net change in cash | -1,426,593 | 3,065,545 | -1,154,450 | -1,891,263 |
| Beginning of period | 3,789,342 | 3,045,713 | 3,769,510 | - |
| End of period | 2,362,749 | 3,065,545 | 723,797 | - |
JUPITER NEUROSCIENCES, INC. (JUNS)
JUPITER NEUROSCIENCES, INC. (JUNS)